---

---

symbols : AZNCF   

save search

---

Global Dyslipidemia Drugs Market Set to Reach $30.98 Billion by 2034 with Statins Dominating and PCSK9 Inhibitors Showing Rapid Growth
Published: 2024-03-08 (Crawled : 18:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 8.55% | O: 3.21% H: 0.0% C: -1.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -6.48% | O: -0.68% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.16% | O: -0.08% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 7.04% | O: -0.03% H: 0.62% C: 0.5%
rapid reach global set growth market

---

Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published: 2024-03-07 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 8.55% | O: 3.21% H: 0.0% C: -1.71%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -1.07% | O: 0.08% H: 0.86% C: 0.7%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -6.48% | O: -0.68% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -5.27% | O: -0.02% H: 0.0% C: -2.29%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -10.41% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.16% | O: -0.08% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 7.04% | O: -0.03% H: 0.62% C: 0.5%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| 0.25% | O: -0.02% H: 1.37% C: 0.34%
company report global market

---

Cervical Cancer Global Clinical Trials Review 2024: Clinical Trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
Published: 2024-03-01 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.69% | O: 0.01% H: 0.0% C: -0.43%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 10.8% | O: 0.59% H: 2.06% C: 2.06%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -1.94% | O: -1.27% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 10.43% | O: 0.28% H: 0.75% C: 0.4%
review cancer trials global trial

---

Ionis announces new chief global product strategy officer to lead next phase of commercial growth
Published: 2024-02-29 (Crawled : 14:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 7.1% | O: -3.11% H: 0.0% C: -0.24%
IONS | $42.455 1.47% 1.45% 730K |

Health Technology

| -10.1% | O: 0.82% H: 0.33% C: -3.64%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 8.42% | O: -0.28% H: 0.06% C: -1.55%
global commercial growth

---

PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman
Published: 2024-02-27 (Crawled : 15:30) - biospace.com/
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 7.93% | O: -1.72% H: 2.54% C: 2.54%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -7.47% | O: -1.07% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 7.46% | O: 0.01% H: 0.79% C: 0.6%

---

Global Glucagon-Like Peptide 1 (GLP-1) Agonist Market Analysis Report 2024: A $133.5 Billion in 2030 Featuring Eli Lilly and Co, Pfizer, Sanofi, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk
Published: 2024-02-27 (Crawled : 01:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 7.93% | O: -1.72% H: 2.54% C: 2.54%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -4.26% | O: -2.2% H: 2.39% C: 1.34%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -3.59% | O: -0.94% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 7.46% | O: 0.01% H: 0.79% C: 0.6%
report agonist global market

---

Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2024-02-26 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 8.63% | O: 3.06% H: 0.0% C: -2.34%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -3.96% | O: 0.23% H: 1.16% C: 0.08%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -5.17% | O: -0.19% H: 0.23% C: -2.02%
UTHR | $237.06 1.11% 1.09% 610K |

Health Technology

| 3.28% | O: -0.48% H: 1.17% C: -1.04%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 7.63% | O: 0.38% H: 0.44% C: -0.23%
reach research market

---

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -8.95% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -1.52% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 10.47% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -5.82% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $65.26 -4.38% 5.9K |

Manufacturing

| 28.21% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -14.66% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -9.46% | O: -0.2% H: 0.14% C: -0.48%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -3.61% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -1.67% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -0.92% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -3.77% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -3.85% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.15% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 8.85% | O: -2.81% H: 2.08% C: 1.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -3.5% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

---

PARP Inhibitors Market to reach over USD 10.31 billion by the year 2031 - Exclusive Report by InsightAce Analytic
Published: 2024-02-21 (Crawled : 09:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 9.18% | O: -0.88% H: 1.75% C: -0.29%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -4.55% | O: 0.8% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -4.09% | O: -0.25% H: 0.0% C: 0.0%
KPTI | $1.1 0.92% 0.91% 1.2M |

Health Technology

| -9.92% | O: -1.65% H: 3.36% C: 1.68%
CKPT | $1.44 0.35% 0.35% 180K |

Health Technology

| -27.27% | O: 0.0% H: 1.26% C: -3.03%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 8.93% | O: -1.01% H: 1.1% C: 1.1%
report year reach market

---

Global Incretin Based Drugs Research Report 2023: Market to Reach $64.28 Billion by 2029 from $40 Billion in 2022, Driven by Increasing Prevalence of Diabetes
Published: 2024-02-21 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 9.18% | O: -0.88% H: 1.75% C: -0.29%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -3.76% | O: -0.65% H: 0.62% C: 0.5%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -2.2% | O: -2.33% H: 1.55% C: 1.06%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 8.93% | O: -1.01% H: 1.1% C: 1.1%
report reach research global diabetes market

---

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| Email alert Add to watchlist
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| Email alert Add to watchlist
JAZZ | $108.38 -1.18% -1.19% 400K |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| Email alert Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| Email alert Add to watchlist
cancer cell global growth market

---

Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published: 2024-02-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $558.779 -19.1% 23 |

Health Technology

| 11.76% | O: 3.14% H: 1.92% C: 1.92%
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -6.95% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 1.37% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 13.6% | O: 0.87% H: 0.21% C: -2.23%
LZAGY | $57.57 0.02% 93K |

Professional, Scientific, and T...

| 15.95% | O: 4.07% H: 1.53% C: 1.45%
TMO | News | $577.39 0.49% 0.0% 2M |

Health Technology

| 4.98% | O: 0.56% H: 1.3% C: 1.22%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -6.94% | O: 0.42% H: 1.04% C: 0.97%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.1% | O: -0.91% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -0.36% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -0.53% | O: 0.38% H: 2.44% C: 1.54%
BAX | $40.93 -0.22% 0.0% 2.2M |

Health Technology

| 3.53% | O: 0.33% H: 0.63% C: -0.28%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -2.82% | O: -0.73% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.43% | O: -0.83% H: 0.66% C: 0.38%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.93% | O: -1.1% H: 0.0% C: 0.0%
GLPG | News | $28.78 -2.28% -2.33% 140K |

Health Technology

| -25.29% | O: -1.72% H: 1.8% C: 1.59%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -14.77% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 16.09% | O: 0.28% H: 0.93% C: 0.75%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -5.83% | O: -0.21% H: 0.34% C: 0.07%
report global protein growth market

---

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -6.95% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 1.37% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 13.6% | O: 0.87% H: 0.21% C: -2.23%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -0.36% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -0.53% | O: 0.38% H: 2.44% C: 1.54%
VRTX | $400.66 -1.05% -1.06% 810K |

Health Technology

| -2.68% | O: 0.56% H: 0.49% C: -0.12%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.93% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -14.77% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 16.09% | O: 0.28% H: 0.93% C: 0.75%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -5.83% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

---

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -4.81% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 16.27% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -12.29% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -6.74% | O: 0.14% H: 0.35% C: 0.07%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -1.66% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -4.43% | O: 0.7% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 0.41% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 0.24% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -1.53% | O: -0.18% H: 0.48% C: -1.91%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -2.04% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $15.66 3.57% 3.45% 430K |

Health Technology

| -16.97% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $400.66 -1.05% -1.06% 810K |

Health Technology

| -3.25% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.86% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.47 4.22% 4.05% 690 |

Health Technology

| -8.14% | O: -3.1% H: 1.2% C: -0.8%
INCY | $51.72 0.14% 0.14% 1.5M |

Health Technology

| -10.7% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $201.91 4.52% 4.32% 3.3M |

Health Technology

| -21.07% | O: -3.72% H: 0.58% C: -3.82%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 15.37% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $375.0 -0.02% -0.02% 200K |

Health Technology

| -4.49% | O: -2.3% H: 1.65% C: 0.83%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -7.1% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

---

Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 13.6% | O: -0.57% H: 0.04% C: -1.74%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -2.15% | O: -1.46% H: 1.04% C: 0.97%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| -0.15% | O: 0.09% H: 0.0% C: -0.48%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -1.65% | O: 0.02% H: 0.46% C: -0.14%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -3.12% | O: -0.83% H: 0.7% C: -0.27%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -4.15% | O: -0.64% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.99% | O: -0.86% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 13.8% | O: -1.77% H: 0.46% C: 0.41%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -6.04% | O: -0.4% H: 1.6% C: 1.54%
report health treatment care global market

---

Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published: 2024-02-09 (Crawled : 10:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| -13.24% | O: -0.91% H: 3.88% C: 3.88%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 12.24% | O: -2.6% H: 2.26% C: 1.44%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -7.06% | O: -2.46% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -11.56% | O: 4.66% H: 0.0% C: -3.92%
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -4.53% | O: -0.04% H: 0.11% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -2.47% | O: -0.37% H: 0.21% C: 0.05%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -2.8% | O: 0.33% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.1% | O: 1.11% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 11.54% | O: -1.28% H: 1.05% C: -0.72%
research global market

---

Eplontersen granted U.S. FDA Fast Track designation for patients with transthyretin-mediated amyloid cardiomyopathy
Published: 2024-02-08 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 5.22% | O: -8.5% H: 2.46% C: 2.46%
IONS | $42.455 1.47% 1.45% 730K |

Health Technology

| -15.54% | O: 0.2% H: 1.37% C: 0.68%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 6.46% | O: -6.81% H: 3.02% C: 2.42%
fda granted designation eplontersen

---

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 4.83% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -6.68% | O: 0.41% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -4.7% | O: 0.09% H: 0.39% C: -0.36%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| -1.22% | O: 0.43% H: 0.67% C: 0.21%
BAX | $40.93 -0.22% 0.0% 2.2M |

Health Technology

| 3.3% | O: 0.21% H: 0.24% C: -1.04%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -0.87% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.14% | O: 1.33% H: 0.0% C: 0.0%
BMRN | $91.25 -0.88% -0.89% 1.6M |

Health Technology

| 2.52% | O: -0.38% H: 1.79% C: 0.22%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 5.68% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -13.46% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

---

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K |

Health Technology

| -14.57% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 4.83% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| -6.68% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $65.26 -4.38% 5.9K |

Manufacturing

| 39.56% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -12.86% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -5.76% | O: 0.07% H: 0.42% C: 0.07%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -4.7% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -3.9% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 4.83% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.86 -0.27% -0.02% 16M |

Health Technology

| -0.55% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| -0.87% | O: 1.48% H: 0.0% C: 0.0%
VRTX | $400.66 -1.05% -1.06% 810K |

Health Technology

| -2.7% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 1.14% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $108.38 -1.18% -1.19% 400K |

Health Technology

| -12.06% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 5.68% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $273.085 -0.17% -0.17% 2.5M |

Health Technology

| -13.46% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

---

Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
Published: 2024-02-05 (Crawled : 12:30) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 6.37% | O: -0.17% H: 0.09% C: -2.76%
GNPX | $2.31 6.77% 20K |

Health Technology

| -60.91% | O: 33.84% H: 1.01% C: -15.3%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 7.94% | O: -0.76% H: 0.77% C: 0.0%
reqorsa first lung cancer treat cell expansion therapy study

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---